Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Post-approval studies (Phase 4)Study completedNCT00555438
What this trial is testing

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

Who this might be right for
Major Orthopaedic Surgery and Renal Impairment
Centre Hospitalier Universitaire de Saint Etienne 451
Not applicableUnknownNCT05993533
What this trial is testing

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Who this might be right for
Venous Thromboembolic Disease
Direction Centrale du Service de Santé des Armées 100
Early research (Phase 1)Study completedNCT02152423
What this trial is testing

Enoxamed Study in the Treatment of Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndrome
University of Monastir 50
Not applicableUnknownNCT02898051
What this trial is testing

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism

Who this might be right for
NeoplasmsVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 370
Not applicableUnknownNCT06055907
What this trial is testing

Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients

Who this might be right for
Critical IllnessThrombosis
Medical University of Gdansk 50
Not applicableStudy completedNCT00986635
What this trial is testing

Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

Who this might be right for
Differences in Laboratory Coagulation Parameters
Johann Wolfgang Goethe University Hospital 100
Not applicableNot Yet RecruitingNCT07213713
What this trial is testing

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Who this might be right for
Venous ThromboembolismObese Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Testing effectiveness (Phase 2)Ended earlyNCT02749617
What this trial is testing

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma

Who this might be right for
Anti-Xa Activity
University of British Columbia 2
Post-approval studies (Phase 4)UnknownNCT02957877
What this trial is testing

LMWH Infusion as Anticoagulation for Home HD

Who this might be right for
Endstage Renal Disease
Alice Ho Miu Ling Nethersole Hospital 12
Post-approval studies (Phase 4)UnknownNCT03426982
What this trial is testing

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

Who this might be right for
Myocardial InfarctionVenous ThromboembolismStroke+1 more
Wuhan Asia Heart Hospital 700
Large-scale testing (Phase 3)UnknownNCT04999176
What this trial is testing

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Who this might be right for
CancerRivaroxabanVenous Thromboembolism+1 more
André Luiz Malavasi Longo de Oliveira 440
Not applicableNot Yet RecruitingNCT07365670
What this trial is testing

Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)

Who this might be right for
Congenital Heart DiseaseUnfractionated HeparinAnti Xa Activity
Centre Hospitalier Universitaire de la Réunion 22
Not applicableStudy completedNCT04700670
What this trial is testing

Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured

Who this might be right for
Unfractionated Heparin Treatment
Rennes University Hospital 164
Post-approval studies (Phase 4)Ended earlyNCT00437697
What this trial is testing

Thromboprophylaxis in Critically Ill Patients

Who this might be right for
Venous Thromboembolism
Medical University of Vienna 90
Large-scale testing (Phase 3)Ended earlyNCT04558892
What this trial is testing

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.

Who this might be right for
Nephrotic Syndrome
Military Institute od Medicine National Research Institute 65
Not applicableNot Yet RecruitingNCT07559643
What this trial is testing

The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.

Who this might be right for
Bariatric SurgeryAnti-Xa ActivityVTE (Venous Thromboembolism)+1 more
University College Dublin 180